DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+28.25%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$5.06B
AUM Growth
+$5.06B
(+23%)
Cap. Flow
+$868M
Cap. Flow
% of AUM
17.15%
Top 10 Holdings %
Top 10 Hldgs %
34.58%
Holding
151
New
52
Increased
21
Reduced
21
Closed
24
Top Buys
| 1 |
Biogen
BIIB
|
$110M |
| 2 |
ONCR
Oncorus, Inc.
ONCR
|
$92.1M |
| 3 |
The Oncology Institute
TOI
|
$59M |
| 4 |
CMAX
CareMax, Inc. Class A Common Stock
CMAX
|
$53.3M |
| 5 |
Cytokinetics
CYTK
|
$51.1M |
Top Sells
Sector Composition
| 1 | Healthcare | 69.84% |
| 2 | Industrials | 0.55% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
BioCryst Pharmaceuticals
BCRX
$1.73B
| $43.5M | 0.86% |
5,835,810
+1,379,291
| +31% | +$10.3M |
|
|
CNST
27
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $42M | 0.83% |
1,458,957
+453,470
| +45% | +$13.1M |
|
28
Puma Biotechnology
PBYI
$260M
| $40.6M | 0.8% |
3,959,741
+1,133,414
| +40% | +$11.6M |
|
|
VIVO
29
DELISTED
Meridian Bioscience Inc
VIVO
| $40.4M | 0.8% |
2,161,000
+652,602
| +43% | +$12.2M |
|
|
BDSI
30
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $40M | 0.79% |
9,530,000
+1,894,250
| +25% | +$7.96M |
|
|
AXNX
31
DELISTED
Axonics, Inc. Common Stock
AXNX
| $39.9M | 0.79% |
800,000
+24,000
| +3% | +$1.2M |
|
|
ISEE
32
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $39.9M | 0.79% |
5,767,409
| – | – |
|
|
RETA
33
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $39.6M | 0.78% |
320,000
-128,000
| -29% | -$15.8M |
|
34
QuidelOrtho
QDEL
$1.89B
| $39.5M | 0.78% |
220,000
+89,479
| +69% | +$16.1M |
|
35
Editas Medicine
EDIT
$225M
| $37.8M | 0.75% |
538,721
-450,120
| -46% | -$31.6M |
|
36
Olema Pharmaceuticals
OLMA
$432M
| $33.5M | 0.66% |
+696,191
| New | +$33.5M |
|
|
LUMO
37
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $33.4M | 0.66% |
936,291
| – | – |
|
38
Pulmonx
LUNG
$66M
| $32M | 0.63% |
+463,511
| New | +$32M |
|
|
NUVA
39
DELISTED
NuVasive, Inc.
NUVA
| $31.8M | 0.63% |
+565,000
| New | +$31.8M |
|
40
Sotera Health
SHC
$4.53B
| $30.5M | 0.6% |
+1,111,000
| New | +$30.5M |
|
|
DCPH
41
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $30.2M | 0.6% |
528,585
| – | – |
|
|
ORTX
42
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $30M | 0.59% |
6,949,416
| – | – |
|
43
Kodiak Sciences
KOD
$446M
| $29.7M | 0.59% |
202,406
-294,594
| -59% | -$43.3M |
|
44
Owens & Minor
OMI
$422M
| $29.6M | 0.59% |
1,096,000
-381,000
| -26% | -$10.3M |
|
45
Annexon
ANNX
$229M
| $29.2M | 0.58% |
1,167,826
-450,000
| -28% | -$11.3M |
|
46
Alphatec Holdings
ATEC
$2.34B
| $29M | 0.57% |
+2,000,000
| New | +$29M |
|
47
Shattuck Labs
STTK
$62.3M
| $28.8M | 0.57% |
+550,000
| New | +$28.8M |
|
48
Protagonist Therapeutics
PTGX
$3.6B
| $27.8M | 0.55% |
1,379,971
+200,000
| +17% | +$4.03M |
|
|
ACCD
49
DELISTED
Accolade, Inc. Common Stock
ACCD
| $27.8M | 0.55% |
638,001
+14,000
| +2% | +$609K |
|
50
Generation Bio
GBIO
$40.4M
| $27.3M | 0.54% |
961,215
| – | – |
|